Rebecca Roscher, MSc, is a Project Manager at the GP Grenzach Produktions GmbH, a Bayer-owned production facility in Grenzach-Wyhlen, Germany, where she leads and supports projects in process engineering, plants and critical utilities. She is a trained scientist in molecular medicine specializing in the research and development of new drug agents/therapeutics focusing on immune therapies and cell and gene therapy platforms. Her interest in pharmaceutical engineering was sparked after joining ISPE in 2020. As the Ex Officio member of the ISPE International Board of Directors for 2024-2025, Rebecca represents and advocates the interests of young professionals as part of the ISPE Emerging Leaders Community of Practice. Within ISPE, she is active on an international level as member of the Communities of Practices ATMPs and Project Management, contributing to guidelines, articles and conferences.
What does it take to stay ahead in the volatile and fast world of pharmaceutical manufacturing? How do we ensure to invest smartly into the future? Join ISPE at the 2025 ISPE Europe Annual Conference, in London, United Kingdom, to hear about why the industry needs to look beyond just acquiring the latest, cutting-edge technology and how good engineering practices drive efficiency, compliance, and...
The expectations for the workforce joining the industry right now are slightly daunting. It can feel like being required to be everything at once: flexible but driven by purpose, extremely adaptable but stable at the core, empathetic but independent, and knowledgeable but versatile.
For decades, success within the pharmaceutical sector was governed and constituted by linear career paths. A linear path, though predictable, may disregard an individual’s personal drivers and goals. Professional success should not only be defined through the height of your ladder position, but also by the alignment of your work to personal interests.
In an era where advanced therapy medicinal products (ATMPs) are revolutionizing healthcare, the 2024 ISPE Pharma 4.0™ and Annex 1 Conference, taking place 10-11 December in Rome, Italy, and...